Altamira Therapeutics Ltd (CYTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1987 | 12-1986 | 12-1985 | 12-1984 | 12-1983 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,193 | -2,240 | -3,906 | N/A | N/A |
| Depreciation Amortization | 1,337 | 293 | 264 | N/A | N/A |
| Other Operating Activity | -511 | 0 | 0 | 0 | 0 |
| Operating Cash Flow | $-3,367 | $-1,947 | $-3,642 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 52 | 727 | 964 | 0 | 0 |
| Investing Cash Flow | $52 | $727 | $964 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 1,929 | 51,399 | 5 | 0 | 0 |
| Financing Cash Flow | $1,929 | $51,399 | $5 | $N/A | $N/A |
| Beginning Cash Position | 5,241 | 3,472 | 465 | N/A | N/A |
| End Cash Position | -8,535 | 45,943 | -2,462 | N/A | N/A |
| Net Cash Flow | $18 | $1,489 | $123 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,367 | -1,947 | -3,642 | N/A | N/A |
| Free Cash Flow | -3,367 | -1,947 | -3,642 | 0 | 0 |